


Ask a doctor about a prescription for Trazodone Neuraxpharm
Trazodone hydrochloride
Trazodone Neuraxpharm contains the active substance trazodone hydrochloride. It belongs to the group of antidepressant medicines. Trazodone Neuraxpharm is used to treat symptoms of depression (episode of severe depression) in adults.
If you have depression, you may sometimes have thoughts of self-harm or suicidal thoughts. These thoughts may worsen when you start taking antidepressant medicines, because these medicines start working only after some time, usually after about 2 weeks, and sometimes later. A greater tendency to such thoughts may occur:
If you ever have thoughts of self-harm or suicidal thoughts, you must immediately
contact your doctor or go to the hospital.
It may be helpful to inform a relative or friendthat you have depression and ask them to read this leaflet. You may ask them to keep an eye on you and inform you if they notice that your depression or anxiety has worsened or if you have made any disturbing changes in your behavior. 
There have been reports of severe liver dysfunction during treatment with Trazodone Neuraxpharm. If you experience any of the following symptoms, you must immediately contact your doctor: 
- weakness (asthenia) 
- loss of appetite (anorexia) 
- nausea, vomiting 
- abdominal pain 
- yellowing of the skin and (or) eyes (jaundice) 
Elderly patients 
Elderly patients taking Trazodone Neuraxpharm may experience dizziness and dizziness when standing up or stretching. They may also feel more sleepy than usual. 
Caution is required, especially if the patient has other conditions and is taking medicines for them, as well as Trazodone Neuraxpharm.
If you have liver, kidney, heart, epilepsy, increased pressure in the eyeball (glaucoma), difficulty urinating, or prostate disorders, your doctor will periodically monitor your health while taking Trazodone Neuraxpharm. 
During treatment with trazodone, severe liver dysfunction resulting in death has been reported. 
You must stop taking Trazodone Neuraxpharm and immediately contact your doctor if you experience yellowing of the skin or the white part of the eye (jaundice), or if you experience symptoms such as weakness (asthenia), loss of appetite, nausea, vomiting, abdominal pain. See section 4. Possible side effects. 
If you have schizophrenia or other mental disorder, taking antidepressant medicines may worsen mental symptoms. Paranoid thoughts may worsen. During treatment with Trazodone Neuraxpharm, a depressive episode of manic-depressive psychosis may turn into a manic episode. In such a situation, taking Trazodone Neuraxpharm must be stopped immediately. 
If you experience a sore throat, fever, or flu-like symptoms while taking Trazodone Neuraxpharm, you must immediately contact your doctor. In such a situation, it is recommended to have a blood test, as these may be clinical symptoms of agranulocytosis, a blood disorder. 
Caution is required if trazodone is taken with other medicines known to prolong the QT interval or with medicines known to increase the risk of serotonin syndrome or malignant neuroleptic syndrome (see section Trazodone Neuraxpharm and other medicines and section 4. Possible side effects). 
Children and adolescents 
Trazodone Neuraxpharm should not be taken by children and adolescents under 18 years of age. 
If you are not sure if any of the above situations apply to you, you should contact your doctor or pharmacist before taking Trazodone Neuraxpharm.
Tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take. 
This includes medicines bought without a prescription, including herbal medicines. Trazodone Neuraxpharm may affect the action of other medicines. Some medicines may also affect the action of Trazodone Neuraxpharm.
If you are scheduled to receive an anesthetic (e.g., during surgery), you should inform your doctor or dentist that you are taking Trazodone Neuraxpharm.
Do not consume alcohol while taking Trazodone Neuraxpharm.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine. If Trazodone Neuraxpharm was taken in the last months of pregnancy, the newborn may experience withdrawal symptoms.
You may experience drowsiness or dizziness. You may also experience blurred vision and disorientation. If these symptoms occur, do not drive or operate tools or machines.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Trazodone Neuraxpharm should not be taken by children and adolescents under 18 years of age.
50 mg tablets: The score line on the tablet is not intended for breaking the tablet. 
100 mg tablets: The tablet can be divided into equal doses. Each half of the tablet contains 50 mg of trazodone hydrochloride. 
150 mg tablets: The tablet can be divided into equal doses. Each half of the tablet contains 75 mg of trazodone hydrochloride.
Improvement usually occurs after two to four weeks. 
After establishing an effective dose, the patient should take it for at least four weeks. 
The doctor will periodically assess the effectiveness of the taken dose and, depending on the patient's condition, decide whether further treatment is necessary. 
Usually, the use of antidepressant medicines should be continued until the patient feels well for a period of four to six months.
If you have taken a higher dose of Trazodone Neuraxpharm than recommended, you should immediately contact your doctor or go to the hospital emergency department. You should take the medicine packaging with you so that the doctor knows what medicine was taken. 
The following symptoms may occur: nausea or vomiting, drowsiness, dizziness, or fainting, seizures (epileptic fits), disorientation, breathing difficulties, or heart problems.
If you miss a dose, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose. 
Do not take a double dose to make up for the missed dose.
Do not stop taking Trazodone Neuraxpharm unless your doctor tells you to. You should not stop taking Trazodone Neuraxpharm just because you feel better. If your doctor decides to stop treatment, they will advise you to gradually reduce the dose to minimize the risk of withdrawal symptoms, such as: agitation, difficulty sleeping, nausea, headache, and malaise. 
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw; tel.: +48 22 49 21 301; fax: +48 22 49 21 309 
Website: https://smz.ezdrowie.gov.pl 
Side effects can also be reported to the marketing authorization holder. 
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. 
Do not use this medicine after the expiry date stated on the carton after "EXP" or on the blister after "EXP". The expiry date refers to the last day of the month stated. 
There are no special storage instructions for this medicine. Store in the original package to protect from light. 
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Other ingredients of the tablets are: microcrystalline cellulose, carbomer (type A), corn starch, colloidal anhydrous silica, and magnesium stearate.
Trazodone Neuraxpharm, 50 mg, are white or almost white, round, biconvex tablets without coating with a score line, 7.14 mm in diameter, with "IT" and "I" embossed on one side and smooth on the other. 
The score line on the tablet is not intended for breaking the tablet. 
Trazodone Neuraxpharm, 100 mg, are white or almost white, round, biconvex tablets with a score line, 9.52 mm in diameter, with "IT" and "II" embossed on one side and smooth on the other. 
The tablet can be divided into equal doses. 
Trazodone Neuraxpharm, 150 mg, are white or almost white, oval, flat tablets without coating with beveled edges, 16.90 mm long and 8.40 mm wide, with a score line, with "IT" and "III" embossed on one side and smooth on the other. 
The tablet can be divided into equal doses. 
The tablets are available in aluminum/aluminum, PVC/PVDC/aluminum, and PVC/aluminum blisters. 
Available pack sizes:
Trazodone Neuraxpharm, 50 mg: 30 tablets in a carton. 
Trazodone Neuraxpharm, 100 mg: 30 tablets in a carton. 
Trazodone Neuraxpharm, 150 mg: 30 or 100 tablets in a carton. 
Not all pack sizes may be marketed.
neuraxpharm Arzneimittel GmbH 
Elisabeth-Selbert Str. 23 
40764 Langenfeld 
Germany
Glenmark Pharmaceuticals s.r.o. 
Fibichova 143 
566 17 Vysoké Mýto 
Czech Republic 
Laboratori Fundació Dau 
C/ C, 12-14 Pol. Ind. Zona Franca 
08040 Barcelona 
Spain 
neuraxpharm Arzneimittel GmbH 
Elisabeth-Selbert Str. 23 
40764 Langenfeld 
Germany
Neuraxpharm Polska Sp. z o.o. 
ul. Poleczki 35 
02-822 Warsaw 
[email protected]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Trazodone Neuraxpharm – subject to medical assessment and local rules.